comparemela.com

Latest Breaking News On - Arcalis inc - Page 1 : comparemela.com

Arcturus Therapeutics : Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan

Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan Meiji Holdings Co., Ltd. Announces that.

Seika pharmaArcalis incArcturus therapeutics incAxcelead incMeiji seika pharma co ltdArcturus therapeutics holdings incMeiji holdings co ltdMedicines companyAdditional applicationBooster doseArcturus therapeuticsMeiji seika pharmaMinami soma cityTherapeutics holdings

Arcturus Therapeutics : Submitted New Drug Application to Manufacture and Market ARCT-154, Next Generation mRNA Vaccine against COVID-19, in Japan - Form 8-K

Submitted New Drug Application to Manufacture and Market ARCT-154, Next Generation mRNA Vaccine against COVID-19, in Japan Meiji Holdings Co., Ltd. announces. | April 28, 2023

Republic ofSeika pharmaArcalis incArcturus therapeutics holdings incArcturus therapeutics incMeiji seika pharma co ltdMeiji holdings co ltdAxcelead incSubmitted new drug applicationNew drug applicationArcturus therapeuticsMeiji seika pharmaMinami soma cityTherapeutics holdingsArcturus therapeutics holdings inc stock exchangePress release

vimarsana © 2020. All Rights Reserved.